|
|||||
A new federal grant supports expansion of a research and development center developing techniques to make the manufacture and integration of microfluidic, or lab-on-a-chip, devices easier and less expensive. . . . → Read More: NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center 
A company developing engineered tissue implants from stem cells received a grant from National Institutes of Health to develop an implant to correct a congenital defect in a newborn infant’s esophagus. . . . → Read More: NIH Award Supports Esophagus Tissue Implants from Stem Cells  Comments are closed  Finance, New products  biomedical, grant, life sciences, NIH, pharmaceuticals, preclinical, stem cells 
National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle. . . . → Read More: NIH Stops Stem Cell Heart Failure Trial Over Retracted Data One comment - (Comments are closed) Regulations biomedical, biotechnology, clinical trials, heart disease, life sciences, NIH, pharmaceuticals, preclinical, stem cells, university 
A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss. . . . → Read More: Trials to Test Stem Cell Treatments for Eye Injuries One comment - (Comments are closed) Finance, New products biomedical, biotechnology, clinical trials, DoD, grant, life sciences, pharmaceuticals, stem cells, university 
The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses. . . . → Read More: Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses Comments are closed New products biomedical, biotechnology, genomics, life sciences, medical device, pharmaceuticals, preclinical, stem cells, university 
A company developing treatments for heart disease using stem cells to regenerate healthy heart tissue received two new patents for techniques supporting its core processes. . . . → Read More: Patents Awarded for Stem Cell Heart Disease Technologies Comments are closed Intellectual property biomedical, clinical trials, engineering, heart disease, life sciences, medical device, patent, pharmaceuticals, stem cells, USPTO 
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments Comments are closed Finance, Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, stem cells, university, venture capital 
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled 2 comments - (Comments are closed) Finance, Intellectual property biomedical, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, stem cells, university, venture capital 
A university bioengineering group developed a model of a left ventricle, the heart chamber that pumps blood to the body, made with engineered heart muscle tissue to replace animals for drug testing. . . . → Read More: Tissue-Engineered Heart Chamber Model Developed One comment - (Comments are closed) New products biomedical, engineering, heart disease, life sciences, materials science, medical device, nanotechnology, patent, physical sciences, stem cells, university 
A tissue engineering team developed a process that includes computer-assisted design for personalized grafts derived from a patient’s own stem cells, to repair bone defects caused by trauma or disease. . . . → Read More: Computer-Aided Bone Graft Process Devised with Stem Cells One comment - (Comments are closed) New products biomedical, engineering, life sciences, materials science, medical device, pharmaceuticals, physical sciences, software, stem cells |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
